Patents Assigned to Allosteros Therapeutics, Inc.
  • CaMKII inhibitors and uses thereof
    Patent number: 9951061
    Abstract: The present invention provides compounds useful as inhibitors of Ca2+/calmodulin-dependent protein kinase (CaMKII), compositions thereof, and methods of using the same.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: April 24, 2018
    Assignee: Allosteros Therapeutics, Inc.
    Inventors: Daniel E. Levy, Howard Schulman, Bheema Paraselli, Erin Bradley, Sampath K. Nangunoori, Brahmaiah Dabbugoddu, Isabelle Lehoux
  • CaMKII INHIBITORS AND USES THEREOF
    Publication number: 20160024078
    Abstract: The present invention provides compounds useful as inhibitors of Ca2+/calmodulin-dependent protein kinase (CaMKII), compositions thereof, and methods of using the same.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 28, 2016
    Applicant: Allosteros Therapeutics, Inc.
    Inventors: Daniel E. Levy, Howard Schulman, Bheema Paraselli, Erin Bradley, Sampath K. Nangunoori, Brahmaiah Dabbugoddu, Isabelle Lehoux